What development phase is N-(Isopropylamino)-2-Pyrimidine in?

N-(Isopropylamino)-2-Pyrimidine is FDA-approved (marketed).

What is the generic name of N-(Isopropylamino)-2-Pyrimidine?

ISAXONINE is the generic (nonproprietary) name of N-(Isopropylamino)-2-Pyrimidine.

Last reviewed 2026-05-14 · How we verify

N-(Isopropylamino)-2-Pyrimidine (ISAXONINE)

FDA-approved withdrawn Small molecule Quality 6/100

At a glance

Generic name	ISAXONINE
Drug class	isaxonine
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

N-(Isopropylamino)-2-Pyrimidine CI brief — competitive landscape report
N-(Isopropylamino)-2-Pyrimidine updates RSS · CI watch RSS